Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Johnson & Johnson (NY: JNJ)
86.36 USD  +0.73 (+0.85%)
Official Closing Price  /  Updated: 4:15 PM EDT, Jun 18, 2013  /  Add to My Watchlist      
View: Quote News Research
All news about Johnson & Johnson
 
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Option Trends: Johnson & Johnson (JNJ), General Motors (GM), and Nokia Corporation (ADR) (NOK)
Today 12:19 EDT
Speculative players have been taking sides on blue chip Johnson & Johnson (NYSE:JNJ), automaker General Motors Company (NYSE:GM), and Finnish telecom concern Nokia Corporation (ADR) (NYSE:NOK),... Read More
category JNJ
from SchaeffersResearch.com Market Observations
The NIH Aims To Develop Drugs That Big Pharma Discarded
Today 12:16 EDT
This morning, the National Institutes of Health awarded $12.7 million to nine academic groups to test potential medicines for diseases including Alzheimer's disease, Duchenne muscular dystrophy, and... Read More
category NYSE:JNJ , NASDAQ:CBST , NYSE:PFE , and 2 more.
from Forbes Real Time
Johnson & Johnson (JNJ) higher on buying Aragon
Today 11:46 EDT
Johnson & Johnson (NYSE: JNJ) shares eked higher 0.4% to $85.97, after it announced Monday a definitive agreement to acquire Aragon Pharmaceuticals for an upfront cash payment of $650 million, plus... Read More
from BAYSTREET RSS FEED
Notable ETF Inflow Detected - IVV, XOM, JNJ, CVX
Today 11:11 EDT
Symbols mentioned in this story: IVV, XOM, JNJ, CVX Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''... Read More
category ETFs
from ETF Channel
Medivation’s Xtandi Threatened by J&J’s New Acquisition
Today 10:55 EDT
One of the biotech laggards of the year, Medivation (NASDAQ: MDVN) saw a very high volume selloff (-6.78% ?$47.41/share) yesterday after rival Johnson & Johnson (NYSE: JNJ) announced the acquisition of... Read More
category JNJ , Bio/Wire , MDVN
from Bio-Wire.Com
Need Income? You Need Covered Calls
Today 10:11 EDT
 Read More
category NYSE:JNJ , Options 101
from InvestorPlace - Latest Headlines
Where to put your money for a long, hot summer
Today 6:30 EDT
With U.S. stocks struggling to break new ground and a rise in Treasury yields upsetting the bond market, money managers are recommending a mix of proven blue-chips and exchange-traded products to... Read More
category VIVHY , MLPI , MCD , and 44 more.
from MarketWatch
5 Stocks With Strong Earnings Growth — MIL MA MXWL AEGN JNJ
Today 5:55 EDT
 Read More
category NYSE:JNJ , NYSE:MA , Stocks to Buy , and 3 more.
from InvestorPlace - Latest Headlines
Market Wrap: Empire Manufacturing State of Mind; Weyerhaeuser Purchases; Walter Continues Slide
June 17, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8424079 for the full story. Read More
from StreetInsider.com News Articles
Benzinga's M&A Chatter for Monday June 17, 2013
June 17, 2013
The following are the M&A deals, rumors and chatter circulating on Wall Street for Monday June 17, 2013: Starboard Says Sum of Smithfield Parts Worth More than $34/Share Offer The Shareholder... Read More
category OSH , Rumors , Benzinga , and 9 more.
from Latest Articles from Benzinga.com
Keep Up-to-Date with Current Health Sector Issues : Johnson & Johnson , Boston Scientific Corporation.
June 17, 2013
New York, NY -- (SBWIRE) -- 06/17/2013 -- Johnson & Johnson (NYSE:JNJ) said Thursday it has decided to buy Aragon Medication Inc. for at least $650 thousand in money, enhancing its position in prostate... Read More
from SBWire - Latest Press Releases
Daily Wrap: June 17, 2013
June 17, 2013
Stocks pared earlier gains, as investors grow more nervous every day with regard to the timing of the Federal Reserve decision to reduce bond purchases The Federal Open Market Committee Meeting begins... Read More
category Stocks
from Market News Video
Bio-Wire Equity Surveillance – Closing Bell 6/17/2013
June 17, 2013
Monday, June 17th, 2013 DJIA: +.73% ?15,179.85 S&P 500: +.76% ?1,639.04 NASDAQ: +.83% ?3,452.13 NASDAQ Biotech: -.81% ?1,817.88 NYSE Arca – Pharma Index: +.30% ?430.35 Big pharma (Mkt Cap $10 B+) +.04%... Read More
category AEGR , Bio/Wire , VPHM , and 4 more.
from Bio-Wire.Com
Market Wrap for Tuesday, June 17: Stocks Jump to Start Trading Week; Dow Rallies Triple Digits
June 17, 2013
The U.S. stock market rose on Monday after a series of volatile moves last week. Investors snapped up shares on expectations that the Federal Reserve will reinforce its commitment to monetary stimulus... Read More
category Earnings , Benzinga , RXN , and 29 more.
from Latest Articles from Benzinga.com
Market Wrap-Up for June 17 (WY, JNJ, LOW, more)
June 17, 2013
Ahead of the Federal Reserve’s two-day FOMC meeting this week, a wave of bullish sentiment flowed through the markets, sending the indices into positive territory early in the day’s session. After... Read More
category twc , agnc , wy , and 7 more.
from Dividend Daily
Markets Advance On Fed Hopes
June 17, 2013
The markets advanced during the midday with the Dow leaping 171 points to 15,241 as investors grew more confidant that the Federal Reserve would maintain its bond buying program. Nasdaq jumped 43... Read More
category Market News
from MarketMinute.com Market Updates
Midday Movers: ERJ, UTX, MDVN & More
June 17, 2013
Take a look at some of Monday's midday movers: Read More
category Cisco Systems Inc , ViroPharma Inc , Johnson and Johnson , and 2 more.
from CNBC.com News
J&J to Buy Aragon Pharmaceuticals for $1B
June 17, 2013
 Read More
category NYSE:JNJ , Market Insight: Financial Articles
from InvestorPlace - Latest Headlines
Streetinsider.com's Hot Lunchtime Reads 06/17: (MSFT) (VPHM) (ISRG) (FB)
June 17, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8422604 for the full story. Read More
from StreetInsider.com News Articles
Investors Pick: Johnson & Johnson (NYSE:JNJ) and Sony Corp. (NYSE:SNE)
June 17, 2013
Charleston, SC -- (SBWIRE) -- 06/17/2013 -- The Team of advisers at Capital Equity Report are committed to bringing you stock picks that are noteworthy and priced at a great value. We work for you and... Read More
from SBWire - Latest Press Releases
Johnson & Johnson Acquires Prostate Cancer Drug
June 17, 2013
This morning, Johnson & Johnson (JNJ) announced it would buy Aragon Pharmaceuticals for as much as $1 billion. Aragon Pharmaceuticals is a privately held company and as part of the deal would receive... Read More
category Stocks
from Market News Video
UPDATE 1-J&J, in new $1 bln deal, bolsters prostate-cancer role
June 17, 2013
By Ransdell Pierson June 17 (Reuters) - Johnson & Johnson said it would pay up to $1 billion for Aragon Pharmaceuticals and its experimental drugs for prostate cancer, bolstering J&J's role in the... Read More
category companyNews
from Reuters: Company News
Medivation (MDVN) Decline Tied to J&J (JNJ) / Aragon Deal
June 17, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8422437 for the full story. Read More
from StreetInsider.com News Articles
This Week’s Seminal Event
June 17, 2013
category Market/Outlook , Week/Ahead , Market/Outlook/2013/Q2 , and 1 more.
from Wall Street Greek
Notable Mergers and Acquisitions of the Day 06/17: (WY) (JNJ) (BIOS) (CBT)
June 17, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8422095 for the full story. Read More
from StreetInsider.com News Articles
Johnson & Johnson to Acquire Aragon Pharmaceuticals (JNJ)
June 17, 2013
On Monday, healthcare product company, Johnson & Johnson (JNJ) announced that it will acquire Aragon Pharmaceuticals. Aragon, which is a private company that is currently in a mid-stage clinical trial... Read More
category johnson & johnson , jnj , Dividend Stocks
from Dividend Daily
Johnson & Johnson (JNJ) Acquires Privatly-Held Aragon Pharmaceuticals for $650M, Plus Contingencies
June 17, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8421539 for the full story. Read More
from StreetInsider.com News Articles
Johnson & Johnson to buy Aragon for up to $1 billion
June 17, 2013
June 17 (Reuters) - Johnson & Johnson said on Monday that it would buy Aragon Pharmaceuticals, a private company that is running a mid-stage clinical trial for a prostate cancer drug, for $650 million... Read More
category companyNews
from Reuters: Company News
Johnson & Johnson Announces Definitive Agreement To Acquire Aragon Pharmaceuticals, Inc.
June 17, 2013
Late-Stage Prostate Cancer Treatment Strengthens Oncology Pipeline Read More
from PR Newswire
The Real Story Behind AIG, KO, JNJ and PG
June 17, 2013
from Marketwired News Releases
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here

WHAT'S POPULAR IN THE VILLE

1
The QE Carry Trade Is Imploding Right Under Everyone's Noses
Vince Foster
2
Immunotherapy: Four Companies on the Verge of Cancer-Treatment Breakthroughs
TM Meyer
3
What Now, Mr. Bernanke? Traders Position Into the FOMC Rate Decision
Todd Harrison
4
Is Netflix, Inc the Next HBO? DreamWorks Animation Skg Inc Deal Hits Big Cable Where It Hurts
Carol Kopp
5
In Insider Trading, Phillip Frost Increases Stake in Opko Health Inc. and Larry Page Sells Shares of Google Inc
Jonathan Moreland